Suchergebnisse - "Köhler, Philipp"

PubPharm (213)

1

Longitudinal multi-omics analysis identifies responses of megakaryocytes, erythroid cells and plasmablasts as hallmarks of severe COVID-19 trajectories

enthalten in: bioRxiv.org | 2024

von Bernardes, J. | Mishra, N. | Tran, F. | +67

2

IgA autoantibodies target pulmonary surfactant in patients with severe COVID-19

enthalten in: bioRxiv.org | 2024

von Sinnberg, T. | Lichtensteiger, C. | Ali, O. | +21

3

Impact of shift work and other work-related factors on anti-SARS-CoV-2 spike-protein serum concentrations in healthcare workers after primary mRNA vaccination - a retrospective cohort study

enthalten in: Swiss medical weekly | 2024

von Menghini, G. | Thurnheer, R. | Kahlert, C. | +5

4

Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies-an Exploratory Study

enthalten in: Mycopathologia | 2024

von Aerts, R. | Ricaño-Ponce, I. | Bruno, M. | +17

5

Evolution of symptoms compatible with post-acute sequelae of SARS-CoV-2 (PASC) after Wild-type and/or Omicron BA.1 infection : A prospective healthcare worker cohort

enthalten in: The Journal of infection | 2024

von Strahm, C. | Kahlert, C. | Güsewell, S. | +4

6

Regional spread of an atypical ESBL-producing Escherichia coli ST131H89 clone among different human and environmental reservoirs in Western Switzerland

enthalten in: Antimicrobial agents and chemotherapy | 2024

von Martischang, R. | Seth-Smith, H. | Verschuuren, T. | +11

7

S-Gene Target Failure as an Effective Tool for Tracking the Emergence of Dominant SARS-CoV-2 Variants in Switzerland and Liechtenstein, Including Alpha, Delta, and Omicron BA.1, BA.2, and BA.4/BA.5

enthalten in: Microorganisms | 2024

von Hilti, D. | Wehrli, F. | Berchtold, S. | +11

8

Crystalline forms of the 4-pyrimidinesulfamide derivative aprocitentan

enthalten in: Europäisches Patentamt | 2024

von BOLLI MARTIN | KOHLER PHILIPP | SCHINDELHOLZ IVAN | +1

9

Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases

enthalten in: Europäisches Patentamt | 2024

von BELLET MARC | BOLLI MARTIN | CLOZEL MARTINE | +4

10

Development of hybrid immunity during a period of high incidence of Omicron infections

enthalten in: International journal of epidemiology | 2023

von Frei, A. | Kaufmann, M. | Amati, R. | +112

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]